Human gut flora
The human gut flora, also referred to as the gut microbiota or intestinal microbiome, comprises the vast and diverse community of microorganisms — predominantly bacteria, but also archaea, fungi, viruses, and protists — that colonize the gastrointestinal tract.
The human gut flora, also referred to as the gut microbiota or intestinal microbiome, comprises the vast and diverse community of microorganisms — predominantly bacteria, but also archaea, fungi, viruses, and protists — that colonize the gastrointestinal tract. Estimated to harbor trillions of microbial cells encoding tens of millions of genes, this ecosystem represents one of the most complex and metabolically active environments in the human body. The dominant bacterial phyla in healthy adults include Firmicutes, Bacteroidota (formerly Bacteroidetes), Actinobacteria, and Proteobacteria, with their relative abundances shaped by host genetics, age, diet, geographic origin, and pharmaceutical exposures.
Far from being passive residents, gut microorganisms perform critical physiological functions: fermenting dietary fiber into short-chain fatty acids (SCFAs), synthesizing vitamins, educating and calibrating the host immune system, maintaining intestinal barrier integrity, modulating bile acid metabolism, and producing a broad repertoire of bioactive metabolites that circulate systemically. Disruption of this community — termed dysbiosis — has been linked to an expanding spectrum of conditions extending well beyond the gastrointestinal tract, including metabolic disorders, neurodegenerative diseases, cancers, autoimmune conditions, and psychiatric illnesses. The gut microbiota's capacity to influence remote organ systems via the gut-liver axis, gut-lung axis, and microbiota-gut-brain axis has positioned it as a central subject in translational medicine and multi-omics research.
Where the papers sit
17 papers from the last 6 months study human gut flora directly · updated from PubMed 12 Nov 2026
Study type 1 clinical trial · 2 observational · 1 human data · 7 preclinical · 6 unclassified
Themes one subject · 1 new direction
Those 17 are all about one subject.
-
Gut Microbiota and Health
Microbiota dysbiosis and microbial metabolites recur as links between diet, obesity, infection, aging, and systemic disease. Studies connect bile acids, tryptophan, linoleic acid, and other metabolites with intestinal barrier function, inflammation, immunity, and treatment response. Dietary compounds, plant extracts, Nigella sativa, and microbiota-directed strategies are explored as ways to restore metabolic or immune balance. The set remains broad, with observational associations, mechanistic animal work, and early human intervention studies rather than one settled therapeutic direction.
Gut microbiota is a transferable regulator of nanomedicine pharmacokinetics
Nanomedicine clearance and tumour delivery in germ-free and microbiota-manipulated mice were the subject of the study by PMID 42538384. Whereas the other papers use gut flora mainly as a contributor to disease phenotypes, immune states, metabolic pathways, or responses to biological treatments, this study found that gut-bacteria-derived bile acids program Kupffer-cell phagocytosis, thereby determining hepatic sequestration and the biodistribution of nanomedicines. Fecal transfer transmitted the low-clearance phenotype across multiple tumour models and nanomedicine formulations, making gut microbiota a transferable host pharmacokinetic determinant and a potential means of controlling drug delivery rather than merely a disease-related or treatment-associated variable.
Papers
The 17 papers from the last 6 months that study human gut flora directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Gut Microbiota and Health (17)
- Microplastic exposure and obesity-related metabolic dysfunction: A proposed gut microbiota-metabolite framework. NanoImpact · 2 Nov 2026 PMID 42971402
- Understanding pathophysiology of gallstone disease: a multi-omic analysis focused on adult women with obesity. International journal of obesity (2005) · 16 Oct 2026 PMID 42888205
- Comparative gut microbiome in diarrheal and non-diarrheal children: an individually matched case-control study. mSystems · 30 Sept 2026 PMID 42813801
- Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging. Gut microbes · 17 Sept 2026 PMID 42750596
- Chronic administration of a calafate (Berberis microphylla) polyphenol-rich extract modulates gut microbiota and metabolic homeostasis associated with thermogenic activation in high-fat diet-fed mice. Journal of physiology and biochemistry · 16 Sept 2026 PMID 42747643
- A prospective randomized controlled pilot study of gut microbiome modulation by Nigella sativa seed oil and thymoquinone metabolism in healthy volunteers: implications for gastrointestinal surgery. Scientific reports · 16 Sept 2026 PMID 42744850
- An upside of obesity: Diet-microbe synergy aids immunotherapy. Cell host & microbe · 9 Sept 2026 PMID 42715998
- Gut Microbiota-Isoallolithocholic Acid Crosstalk Promotes Calcium Oxalate Kidney Stone Formation via PARP1-Mediated Parthanatos. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 29 Aug 2026 PMID 42666033
- Gut microbiome signatures during acute infection are associated with long COVID. Gut microbes · 19 Aug 2026 PMID 42615987
- Melatonin Ameliorates Neuropathic Pain in Mice by Regulating Pyroptosis Through Gut Microbiota-Mediated Linoleic Acid. Molecular neurobiology · 15 Aug 2026 PMID 42603252
- Use, understanding, and perceptions of gut microbiome research and practices in oncology. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 12 Aug 2026 PMID 42584704
- A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nature materials · 31 Jul 2026 PMID 42538384
- Metabolic Mechanisms of Modified Lingguizhugan Decoction in Obesity and Lipid Metabolism Disorders: A Multi-Omics Approach. Obesity science & practice · 14 Jul 2026 PMID 42445565
- Lycium ruthenicum Murray anthocyanins alleviate neuroinflammation in MPTP-induced Parkinson's disease by modulating gut microbiota and tryptophan metabolism. International immunopharmacology · 20 Jun 2026 PMID 42322853
- Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD. Digestive diseases and sciences · 19 Jun 2026 PMID 42319657
- Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice via the microbiota-autophagy-stem cell axis. Food & function · 19 Jun 2026 PMID 42316995
- Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies. The European respiratory journal · 11 Jun 2026 PMID 42276744
By study type
Clinical trials (1)
- A prospective randomized controlled pilot study of gut microbiome modulation by Nigella sativa seed oil and thymoquinone metabolism in healthy volunteers: implications for gastrointestinal surgery. Scientific reports · 16 Sept 2026 PMID 42744850
Observational studies and case reports (2)
- Comparative gut microbiome in diarrheal and non-diarrheal children: an individually matched case-control study. mSystems · 30 Sept 2026 PMID 42813801
- Gut microbiome signatures during acute infection are associated with long COVID. Gut microbes · 19 Aug 2026 PMID 42615987
Human data, design not indexed (1)
- Use, understanding, and perceptions of gut microbiome research and practices in oncology. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 12 Aug 2026 PMID 42584704
Preclinical: animal, cell and lab studies (7)
- Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging. Gut microbes · 17 Sept 2026 PMID 42750596
- Chronic administration of a calafate (Berberis microphylla) polyphenol-rich extract modulates gut microbiota and metabolic homeostasis associated with thermogenic activation in high-fat diet-fed mice. Journal of physiology and biochemistry · 16 Sept 2026 PMID 42747643
- An upside of obesity: Diet-microbe synergy aids immunotherapy. Cell host & microbe · 9 Sept 2026 PMID 42715998
- Melatonin Ameliorates Neuropathic Pain in Mice by Regulating Pyroptosis Through Gut Microbiota-Mediated Linoleic Acid. Molecular neurobiology · 15 Aug 2026 PMID 42603252
- A transferable gut microbiota-bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nature materials · 31 Jul 2026 PMID 42538384
- Lycium ruthenicum Murray anthocyanins alleviate neuroinflammation in MPTP-induced Parkinson's disease by modulating gut microbiota and tryptophan metabolism. International immunopharmacology · 20 Jun 2026 PMID 42322853
- Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice via the microbiota-autophagy-stem cell axis. Food & function · 19 Jun 2026 PMID 42316995
Unclassified: not yet indexed with MeSH (6)
- Microplastic exposure and obesity-related metabolic dysfunction: A proposed gut microbiota-metabolite framework. NanoImpact · 2 Nov 2026 PMID 42971402
- Understanding pathophysiology of gallstone disease: a multi-omic analysis focused on adult women with obesity. International journal of obesity (2005) · 16 Oct 2026 PMID 42888205
- Gut Microbiota-Isoallolithocholic Acid Crosstalk Promotes Calcium Oxalate Kidney Stone Formation via PARP1-Mediated Parthanatos. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 29 Aug 2026 PMID 42666033
- Metabolic Mechanisms of Modified Lingguizhugan Decoction in Obesity and Lipid Metabolism Disorders: A Multi-Omics Approach. Obesity science & practice · 14 Jul 2026 PMID 42445565
- Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD. Digestive diseases and sciences · 19 Jun 2026 PMID 42319657
- Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies. The European respiratory journal · 11 Jun 2026 PMID 42276744
Written from 17 PubMed abstracts, each one listed by PMID above. Published: 2026-06-14. Last written: 2026-09-19 by GPT. Drafted by language models from published abstracts; not medical advice.